Bob Saunders, Chairman & Co-founder
Bob is a General Partner of OCA Ventures (Chicago), a Founding Partner of Saunders Murdoch and Associates (Louisville/Boston), and is an active investor in many healthcare startups. Bob was a Managing Director and General Partner at Chrysalis Ventures from 1997 to 2009. Bob was a founding board member of MetaCyte Business Lab, the University of Louisville’s life science incubator. Over the last 30 years, he has invested in several dozen startup companies and has mentored 100+ startups. Bob received a B.A. from Stanford University, an M.Sc. from the London School of Economics, and an M.A. from Harvard University. He was both a Fulbright Scholar and a Marshall Scholar.
Jackie Willmot, CEO & Co-founder
Jackie has over 30 years of experience in the healthcare industry and works as a Venture Consultant with startup organizations. In addition to her role as CEO of XLerateHealth, Jackie is the Vice President of Prenatal Diagnostics at NX PharmaGen and leads the Partner Development efforts at THRIVE365, a diabetes oriented startup that originated within Kraft Foods. Jackie has a B.S.N. from Villa Maria College, an M.S.N. from the University of Pittsburgh and an M.B.A. from the University of Louisville.
Mr. Langdon’s background is in corporate and product strategy for technology businesses. He has experience in executive management, business development,marketing and public relations, acquisitions, product management, software architecture and development, project management and digital electronics design.
Concurrent with her PhD work at Yale University, Rebecca completed internships both in Yale’s Office of Cooperative Research and in the Lead Discovery department at Bristol-Myers Squibb. As such, she has seen technology development through several distinct lenses and hopes to learn more from the XLerateHealth team about the interface of academia, biotechnology, and business. Rebecca is a Neuroscience PhD candidate at Yale University. She received her B.S. in Neuroscience from Brown University.
Executive with over 18 years experience designing, developing, and implementing new products, services, and business models.
Professional focus is on making entrepreneurial endeavors a reality for enterprises of all sizes. Recent professional highlights include introducing a first-of-its-kind retail-health clinical trial model and leading the cross-functional launch of 11 new products in less than 18 months in a highly-matrixed organization.
Elizabeth joined Chrysalis in 2007 and provides research and analytical support to the investment team for Chrysalis’ primary investment sectors: healthcare and technology.